冠状动脉支架内再狭窄的研究进展

被引：28

作者：

杨娜

赵学忠

王全伟

田晓庆

郝守艳

机构：

[1] 吉林大学白求恩第一医院

来源：

中国老年学杂志 | 2014年 / 34卷 / 06期

关键词：

支架内再狭窄; 预测因素; 发病机制; 预防策略; 治疗进展;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

100201 [内科学];

摘要：

<正>随着科学技术的发展和人民生活水平的提高,经皮冠状动脉介入治疗(PCI)已成为治疗冠状动脉粥样硬化性心脏病(简称冠心病)的主要手段。然而,PCI治疗面临着支架内再狭窄的巨大挑战。支架内再狭窄(ISR)通常指经皮冠状动脉介入术后,随访时冠状动脉造影显示其血管内径再次狭窄≥50%。在

引用

页码：1731 / 1733

页数：3

共 16 条

[1]

冠心病PCI术后再狭窄的临床分析 [J].

陈晓洋 ;

涂良珍 .

心血管康复医学杂志, 2011, 20 (04) :361-364

[2]

药物洗脱支架与支架内再狭窄 [J].

张新勇 ;

马长生 .

临床心血管病杂志, 2009, 25 (07) :486-487

[3]

Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: a longitudinal population-based study [J].

Hardoon, Sarah L. ;

Whincup, Peter H. ;

Petersen, Irene ;

Capewell, Simon ;

Morris, Richard W. .

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 (09) :770-774

[4]

Mechanisms of In-Stent Restenosis After Drug-Eluting Stent Implantation Intravascular Ultrasound Analysis [J].

Kang, Soo-Jin ;

Mintz, Gary S. ;

Park, Duk-Woo ;

Lee, Seung-Whan ;

Kim, Young-Hak ;

Lee, Cheol Whan ;

Han, Ki-Hoon ;

Kim, Jae-Joong ;

Park, Seong-Wook ;

Park, Seung-Jung .

CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (01) :9-14

[5]

Difference in risk factors between acute coronary syndrome and stable angina pectoris in the Japanese: Smoking as a crucial risk factor of acute coronary syndrome [J].

Yagi, Hidenori ;

Komukai, Kimiaki ;

Hashimoto, Koichi ;

Kawai, Makoto ;

Ogawa, Takayuki ;

Anzawa, Ryuko ;

Minai, Kosuke ;

Nagoshi, Tomohisa ;

Ogawa, Kazuo ;

Taniguchi, Ikuo ;

Yoshimura, Michihiro .

JOURNAL OF CARDIOLOGY, 2010, 55 (03) :345-353

[6]

Estimating the Risks and Benefits of Nicotine Replacement Therapy for Smoking Cessation in the United States [J].

Apelberg, Benjamin J. ;

Onicescu, Georgiana ;

Avila-Tang, Erika ;

Samet, Jonathan M. .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 100 (02) :341-348

[7]

Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders? [J].

Balakumar, Pitchai ;

Kaur, Jagdeep .

PHARMACOLOGICAL RESEARCH, 2009, 60 (05) :361-368

[8]

Drug-Eluting Stents: Preventing Restenosis.[J].Leo Slavin;Ankush Chhabra;Jonathan M. Tobis.Cardiology in Review.2007, 1

[9]

Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta [J].

Peuster, Matthias ;

Hesse, Carola ;

Schloo, Tirza ;

Fink, Christoph ;

Beerbaum, Philipp ;

von Schnakenburg, Christian .

BIOMATERIALS, 2006, 27 (28) :4955-4962

[10]

Bare metal stent restenosis is not a benign clinical entity [J].

Chen, Michael S. ;

John, Jim M. ;

Chew, Derek P. ;

Lee, David S. ;

Ellis, Stephen G. ;

Bhatt, Deepak L. .

AMERICAN HEART JOURNAL, 2006, 151 (06) :1260-1264

← 1 2 →